Joseph Meletiadis - Infectious Diseases

Author Information

Joseph Meletiadis is a distinguished researcher affiliated with the Clinical Microbiology Laboratory at Attikon University Hospital, part of the National and Kapodistrian University of Athens, located in Athens, Greece. His work primarily focuses on infectious diseases with a strong emphasis on fungal infections and antifungal susceptibility testing. Joseph Meletiadis's expertise is well-recognized in the scientific community, particularly in the study of Aspergillus species and antifungal resistance.

Research Contributions

Joseph Meletiadis has made significant contributions to the field of infectious diseases, particularly in the study of fungal pathogens and their resistance mechanisms. In 2022, his research explored the efficacy of various diagnostic assays and susceptibility testing methods for fungi, including the Dynamiker® Fungus (1–3)-β-d-Glucan Assay for invasive aspergillosis and automated MIC reading of antifungal susceptibility testing. His work also covers the challenges in species identification and antifungal susceptibility testing of rare yeasts, and he has provided insights into the importance of expected phenotypes and expert rules in antimicrobial susceptibility testing. In 2021, his studies included the diversity of fungi in beach environments and the clinical management of fungal infections such as aspergillosis and infections caused by Candida albicans.

Aliases

Joseph Meletiadis is also known by several aliases, including J Meletiadis, J. Meletiadis, and Josef Meletiadis. These variations of his name may appear in different publications and databases.

Publication and Citation Metrics

Metric	Value
Total Citation Count	10,281
h-index	47
Total Paper Count	213

Publications:

Evaluation of the Dynamiker® Fungus (1–3)-β-d-Glucan Assay for the Diagnosis of Invasive Aspergillosis in High-Risk Patients with Hematologic Malignancies

DOI: 10.1007/s40121-022-00627-7

Year: 2022

Spectrophotometric detection of azole-resistant Aspergillus fumigatus with the EUCAST broth microdilution method: is it time for automated MIC reading of EUCAST antifungal susceptibility testing of Aspergillus species?

DOI: 10.1093/jac/dkac046

Year: 2022

Comment on: Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidia-forming dermatophytes.

DOI: 10.1093/jac/dkac004

Year: 2022

Early phenotypic detection of fluconazole- and anidulafungin-resistant Candida glabrata isolates.

DOI: 10.1093/jac/dkac075

Year: 2022

Fungemia due to Moesziomyces aphidis (Pseudozyma aphidis) in a premature neonate. Challenges in species identification and antifungal susceptibility testing of rare yeasts.

DOI: 10.1016/j.mycmed.2022.101258

Year: 2022

Expected phenotypes and Expert Rules are Important Complements to Antimicrobial Susceptibility Testing.

DOI: 10.1016/j.cmi.2022.03.007

Year: 2022

Aspergillus fumigatus and aspergillosis: From basics to clinics

DOI: 10.1016/j.simyco.2021.100115

Year: 2021

Mycosands: Fungal diversity and abundance in beach sand and recreational waters - Relevance to human health.

DOI: 10.1016/j.scitotenv.2021.146598

Year: 2021

A Corneal Perforation Related to Beauveria Bassiana and Post-Penetrating Keratoplasty Management Discussion

DOI: 10.7759/cureus.15724

Year: 2021

The Role of New Posaconazole Formulations in the Treatment of Candida albicans Infections: Data from an In Vitro Pharmacokinetic-Pharmacodynamic Model

DOI: 10.1128/AAC.01292-20

Year: 2021

How Does Mosquirix Work?

What is the Global Impact of Measles?

What Challenges Exist in Measles Control?

What is the Importance of Respiratory Hygiene?

How Do Pathogens Exploit Host Metabolic Pathways?

What Role Does the Immune System Play?

How Can Chlamydia Be Prevented?

Who Should Not Receive the DTaP Vaccine?

When Should You Seek Medical Attention?

How are Structural Proteins Studied?

Partnered Content Networks

Relevant Topics